Filters
Term Search
You can select from the dropdown list OR enter your own terms to refine the search.
Last Updated: 10/31/2025
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 661 publications
Drug Repurposing Patent Applications October-December 2024.
Journal: Assay and drug development technologies
Published: July 25, 2025
COMT inhibition with entacapone for patients with Parkinson's disease and motor complications: the novelty of continuous infusion.
Journal: Journal of neural transmission (Vienna, Austria : 1996)
Published: July 21, 2025
The device-aided intrajejunal delivery of levodopa-entacapone-carbidopa intestinal gel the treatment of Parkinson's disease: overview of efficacy and safety.
Journal: Expert review of medical devices
Published: May 07, 2025
Discovery of the 2,3-Dihydrobenzopyrane-4-one as a Potent FTO Inhibitor against Obesity-Related Metabolic Diseases.
Journal: Journal of medicinal chemistry
Published: March 28, 2025
A phase I study to evaluate the effect of high-dose carbidopa on levodopa pharmacokinetics.
Journal: Frontiers in pharmacology
Published: March 21, 2025
The "Wearing Off" Phenomenon for Rasagiline, Entacapone, Carbidopa, and Levodopa in the Setting of Parkinson's Disease.
Journal: HCA healthcare journal of medicine
Published: March 12, 2025
Real-world experience with continuous subcutaneous foslevodopa/foscarbidopa infusion: insights and recommendations.
Journal: Journal of neural transmission (Vienna, Austria : 1996)
Published: January 16, 2025
Exploring the risk of adverse drug events in combination with antiparkinsonics and antipsychotics-a two-decade real-world pharmacovigilance analysis based on the FAERS database.
Journal: The international journal of neuropsychopharmacology
Published: December 16, 2024
Biomimetic Approach for Optimal Designing of the Shape and Controlled Release of Therapeutics from Tricompartmental Microcarriers for Managing Parkinson's Disease.
Journal: ACS applied bio materials
Published: December 11, 2024
Levodopa-Entacapone-Carbidopa Intrajejunal Infusion in Advanced Parkinson's Disease - Interim Analysis of the ELEGANCE Study.
Journal: Movement disorders clinical practice
Published: December 05, 2024
In Silico Analysis of Triamterene as a Potential Dual Inhibitor of VEGFR-2 and c-Met Receptors.
Journal: Journal of xenobiotics
Published: November 19, 2024
Clinical pharmacokinetics of levodopa and relevant add-on therapies for Parkinson's disease.
Journal: Expert opinion on drug metabolism & toxicology
Published: November 11, 2024
Last Updated: 10/31/2025